Relationship between cardio-ankle vascular index and N-terminal pro-brain natriuretic peptide in hypertension and coronary heart disease subjects.

[1]  C. Nam,et al.  Association of cardio-ankle vascular index with diastolic heart function in hypertensive patients , 2014, Clinical and experimental hypertension.

[2]  M. Yamada,et al.  Arterial stiffness determined according to the cardio-ankle vascular index(CAVI) is associated with mild cognitive decline in community-dwelling elderly subjects. , 2014, Journal of atherosclerosis and thrombosis.

[3]  P. Whincup,et al.  N‐terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population‐based study , 2014, European journal of heart failure.

[4]  Hongyu Wang,et al.  Arterial stiffness evaluation by cardio-ankle vascular index in hypertension and diabetes mellitus subjects. , 2013, Journal of the American Society of Hypertension : JASH.

[5]  Hongyu Wang,et al.  Descriptive study of possible link between cardioankle vascular index and homocysteine in vascular-related diseases , 2013, BMJ Open.

[6]  A. Saiki,et al.  Effects of body weight reduction on cardio-ankle vascular index (CAVI). , 2013, Obesity research & clinical practice.

[7]  N. Nakamura,et al.  N-terminal pro-brain natriuretic peptide could be a marker of subclinical atherosclerosis in patients with type 2 diabetes , 2013, Heart and Vessels.

[8]  I. Tatsuno,et al.  Send Orders of Reprints at Reprints@benthamscience.net Evaluation of Blood Pressure Control Using a New Arterial Stiffness Parameter, Cardio-ankle Vascular Index (cavi) , 2022 .

[9]  I. Chetter,et al.  Aortic Augmentation Index is Independently Associated With N-Terminal Pro B-type Natriuretic Peptide in Patients With Peripheral Arterial Disease , 2012, Vascular and endovascular surgery.

[10]  R. Schnabel,et al.  Multiple Endothelial Biomarkers and Noninvasive Vascular Function in the General Population: The Gutenberg Health Study , 2012, Hypertension.

[11]  K. Bailey,et al.  Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study. , 2011, Mayo Clinic proceedings.

[12]  T. Ninomiya,et al.  N-Terminal Pro-Brain Natriuretic Peptide and Risk of Cardiovascular Events in a Japanese Community: The Hisayama Study , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[13]  I. Kullo,et al.  Biomarkers of Left Ventricular Hypertrophy and Remodeling in Blacks , 2011, Hypertension.

[14]  E. Kang,et al.  Associations between cardio-ankle vascular index and microvascular complications in type 2 diabetes mellitus patients. , 2011, Journal of atherosclerosis and thrombosis.

[15]  N. Girerd,et al.  N-Terminal Pro-Brain Natriuretic Peptide: A Powerful Predictor of Mortality in Hypertension , 2011, Hypertension.

[16]  H. Yagi,et al.  Cardio-Ankle Vascular Index Could Reflect Plaque Burden in the Coronary Artery , 2011, Angiology.

[17]  H. Nasri,et al.  Relationship between serum N-terminal Pro Brain Natriuretic Peptide (NT-Pro BNP) level and the severity of coronary artery involvements , 2011, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[18]  J. Danesh,et al.  B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective Studies , 2009, Circulation.

[19]  H. Yagi,et al.  Comparison of Atherosclerotic Indicators Between Cardio Ankle Vascular Index and Brachial Ankle Pulse Wave Velocity , 2009, Angiology.

[20]  M. Matsuzaki,et al.  Cardio-Ankle Vascular Index Is Superior to Brachial-Ankle Pulse Wave Velocity as an Index of Arterial Stiffness , 2008, Hypertension Research.

[21]  G. Filippatos,et al.  Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implications. , 2008, Congestive heart failure.

[22]  Hiroshi Ogawa,et al.  Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[23]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[24]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[25]  J. Cohn,et al.  Arterial stiffness as a risk factor for coronary atherosclerosis , 2007, Current atherosclerosis reports.

[26]  J. Higaki,et al.  Relationship between Cardio-Ankle Vascular Index (CAVI) and Carotid Atherosclerosis in Patients with Essential Hypertension , 2007, Hypertension Research.

[27]  A. Dominiczak,et al.  2007 ESH‐ESC Guidelines for the management of arterial hypertension , 2007 .

[28]  Kuniaki Otsuka,et al.  A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). , 2006, Journal of atherosclerosis and thrombosis.

[29]  A. Dobson,et al.  How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review , 2005, BMJ : British Medical Journal.

[30]  T. Mueller,et al.  Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[31]  B. Oh,et al.  Relation between cardio-ankle vascular index and coronary artery calcification or stenosis in asymptomatic subjects. , 2013, Journal of atherosclerosis and thrombosis.

[32]  峠岡 佑典.  Relationship between cardio-ankle vascular index (CAVI) and coronary artery calcification (CAC) in patients with type 2 diabetes mellitus , 2013 .

[33]  N. Ohte,et al.  Plasma N-terminal pro-brain natriuretic peptide levels identifying left ventricular diastolic dysfunction in patients with preserved ejection fraction. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[34]  T. Oyama,et al.  Contradictory effects of β1- and α1- aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI)--CAVI independent of blood pressure. , 2011, Journal of atherosclerosis and thrombosis.

[35]  公則 加藤,et al.  人間ドック受診者におけるN-terminal pro-brain natriuretic peptide測定の意義 , 2011 .

[36]  R. S. Gardnera,et al.  N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure , 2003 .